If you are selected as an award recipient, you and your institution must agree to the following items, including, but not limited to:
Exclusive Use of Funding
The award will be used exclusively to fund the award recipient's research plan. In an effort to maximize the research benefit of the award, the Program encourages that every effort be made to minimize the utilization of the award to cover indirect costs. If required, up to 8% of the award can be directed to indirect costs.
Use of Gilead Product
Proposals utilizing Gilead product(s) are not eligible for funding through the Research Scholars Program. Proposals involving Gilead product(s) should be submitted for review under the Investigator-Sponsored Research Grant Program through our online portal: http://www.gilead.com/research/investigator-sponsored
Submission of research progress and financial accounting reports for review by the Committee are required annually. Funding for the second year is contingent upon Committee chair approval of the research progress report.
The support of the Gilead Sciences Research Scholars Program in Cystic Fibrosis must be acknowledged in any publication or abstracts resulting from research funded by this award.
The host institution shall retain ownership of inventions made by the institution and investigator during the conduct of the research.
Change of Institution or Discontinuation
The Research Scholars Program Coordinator must be notified immediately if the award recipient leaves the host institution or discontinues the research funded by
the Program. In the event award recipient moves to another institution, the award
may be transferred at the sole discretion of the Committee. The new host institution
must also agree to accept the terms and conditions of the existing award. In the
event the host institution or award recipient is unable to complete the research or
desires to discontinue the research before its completion, institution will be required
to return all unexpended funds and any remaining award will be terminated.
Award recipients and their institutions will be required to enter into a written grant agreement with Gilead prior to receipt of funding.